Collection of Plasma Samples From Individuals Initiating Therapy With Entecavir or Tenofovir for Chronic Hepatitis B Virus Infection for the Clinical Evaluation of the Aptima HBV Quant Assay

Trial Profile

Collection of Plasma Samples From Individuals Initiating Therapy With Entecavir or Tenofovir for Chronic Hepatitis B Virus Infection for the Clinical Evaluation of the Aptima HBV Quant Assay

Active, no longer recruiting
Phase of Trial: Phase IV

Latest Information Update: 30 Mar 2017

At a glance

  • Drugs Entecavir (Primary) ; Tenofovir (Primary)
  • Indications Hepatitis B
  • Focus Therapeutic Use
  • Sponsors Hologic
  • Most Recent Events

    • 22 Mar 2017 Planned End Date changed from 1 Sep 2018 to 1 Mar 2018.
    • 11 May 2016 Planned End Date changed from 1 Mar 2016 to 1 Sep 2018.
    • 11 May 2016 Planned primary completion date changed from 1 Mar 2016 to 1 Sep 2018.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top